The single use downstream bioprocessing market involves single-use technologies that are employed in the downstream stage of bioprocessing. These single-use systems are used for the filtration, purification, and concentration of biotherapeutic products. The use of single-use systems provides advantages such as lower capital costs, reduced cleaning and validation requirements, and enhanced flexibility. The growing adoption of single-use technologies is driving the demand for single-use systems in downstream processing.
The Single Use Downstream Bioprocessing Market is estimated to be valued at US$ 1.51 Bn in 2024 and is expected to exhibit a CAGR of 15% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the single use downstream bioprocessing market are 3M, Agilitech, CPC (Colder Products Company), Cytiva Lifesciences, Pall Corporation and Among Others. These players are focusing on new product launches and expansion strategies to strengthen their market share.
The growing demand for biotherapeutics and rising adoption of single-use technologies by biopharmaceutical manufacturers are fueling the demand for single-use downstream processing solutions. Additionally, single-use systems help reduce processing time and lower the risks of cross-contamination.
Geographic expansion into emerging markets is one of the key strategies adopted by leading market players. Countries with growing biologics manufacturing industries, such as China, India, and Brazil, provide growth opportunities for single-use downstream bioprocessing product manufacturers.
Market Key Trends
Continuous downstream processing is a key trend gaining popularity in the single-use downstream bioprocessing market. Continuous bioprocessing provides advantages such as higher product yields, reduced process times, lower facility footprints, and ability to modulate product quality attributes. Leading players are focusing on developing novel continuous bioprocessing solutions by integrating single-use technologies to attract more customers. This emerging technology is expected to transform downstream bioprocessing over the forecast period.
Porter’s Analysis
Threat of new entrants: New entrants finding it challenging due to high initial investments required for setting up manufacturing plants.
Bargaining power of buyers: Buyers have moderate bargaining power due to presence of multiple established players offering substitutable products.
Bargaining power of suppliers: Suppliers have low to moderate bargaining power as there are multiple raw material suppliers and components in the market.
Threat of new substitutes: Threat of substitution is low as single use technology offers distinct advantages over conventional stainless steel based equipment.
Competitive rivalry: Intense competition exists among existing players to capture higher market share.
Geographical Regions
North America region holds the largest market share currently in terms of value due to highly developed biopharmaceutical industry and growing adoption of single use technologies. Majority of commercial biopharmaceutical manufacturing facilities are located in US.
Asia Pacific region is expected to witness fastest growth during the forecast period owing to expanding biopharmaceutical industry, rising investments in biomanufacturing facilities by global pharmaceutical companies and increasing development of novel biologics and biosimilars. Countries like China, India provides cost competitive manufacturing environment.
What Are The Key Data Covered In This Single Use Downstream Bioprocessing Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Single Use Downstream Bioprocessing’s growth between 2024 and 2031.
:- Accurate calculation of the size of the Single Use Downstream Bioprocessing and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Single Use Downstream Bioprocessing Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market’s competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Single Use Downstream Bioprocessing vendors
FAQ’s
Q.1 What are the main factors influencing the Single Use Downstream Bioprocessing?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Single Use Downstream Bioprocessing companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Single Use Downstream Bioprocessing’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author - Money Singh
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc. LinkedIn Profile